T2 Biosystems Strengthens Management Team As Company Prepares For Launch Of Flagship T2Candida™ Diagnostic Test

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the appointment of Sarah Kalil as Chief Operating Officer and Steven Scampini as Vice President of Engineering. Ms. Kalil and Mr. Scampini were both most recently employed by Hologic, a leading manufacturer and supplier of diagnostic, surgical and medical imaging equipment and products. Kalil and Scampini each have significant expertise in key areas related to the Company’s anticipated commercialization of its flagship diagnostic test, T2Candida™, for the rapid and sensitive detection of species-specific Candida directly from a non-blood culture, whole blood specimen in approximately three hours with a limit of detection as low as 1 CFU/mL.

Help employers find you! Check out all the jobs and post your resume.

Back to news